David Matthews

@davidmjourno.bsky.social

Reporting on science and technology policy. International editor at @sciencebusiness.net. I also write for @nature.com. Based in Berlin. https://davidjackmatthews.journoportfolio.com

This piece could take the comparison with the Opium Wars even further - in that you could argue, at a stretch, that (some) US digital products are the modern equivalent of opium. Lucrative for the exporter, rather unhealthy for the population on the receiving end.

POLITICO Europe@politico.eu · last yr.

Ursula von der Leyen’s dash to Donald Trump’s golf resort in Scotland last month to seal an unbalanced trade deal has raised fears among politicians and analysts that Europe has lost the leverage that it once thought it had as a leading global trade power.

I still often think about this story. If the US proves to have massively over-invested in LLMs, should we start considering the credulity of the US's tech media ecosystem, so prone to overhyping new products, a strategic weakness? What will China have invented while the US was obsessed with AI?

Michael Pettis@michaelpettis.bsky.social · last yr.

FT: "“We should not only focus on how much GDP has grown and how many major projects have been built, but also on how much debt is owed,” Xi Jinping told the Central Urban Work Conference." www.ft.com/content/9c19...

Today, we've published a feature that asks a fundamental question for anyone involved in science policy: should we focus less on curing individual diseases like cancer or Alzheimer's, and instead try to understand and slow ageing? sciencebusiness.net/news/drug-de...

Anti-ageing therapies: have we got health research funding wrong?

Last year, researchers published an analysis that made grim reading for anyone hoping to live a much longer, healthier life this century.

sciencebusiness.net

Believe it or not, the EU's new €410 billion European Competitiveness Fund will fund...the Metaverse ("virtual worlds", as Brussels calls it). For how many years does an idea have to be dead before the EU removes it from their policy roster? At least there's no mention of blockchain.

Bild

Since writing this feature, I've had a nagging thought. In part, the article describes how metascientists are trying to find good metrics to measure "disruptive" or "novel" science. But do we actually want them to succeed?

Alexandra Witze@alexwitze.bsky.social · last yr.

There's a fascinating feature out in @nature.com today from @davidmjourno.bsky.social, on whether and why scientific breakthroughs are getting harder to achieve. It's a narrative being discussed by some of the most powerful science officials in the world, such as OSTP director Michael Kratsios. 🧪

There's a fascinating feature out in @nature.com today from @davidmjourno.bsky.social, on whether and why scientific breakthroughs are getting harder to achieve. It's a narrative being discussed by some of the most powerful science officials in the world, such as OSTP director Michael Kratsios. 🧪

Are groundbreaking science discoveries becoming harder to find?

Researchers are arguing over whether ‘disruptive’ or ‘novel’ science is waning – and how to remedy the problem.

nature.com

Fascinating speech by the US's new OSTP director, Michael Kratsios, last week. He accepts the Robert Gordon etc argument that sci/tech has slowed down. "Progress today pales in comparison to the huge leaps of the 20th century." www.whitehouse.gov/articles/202...

Remarks by Director Kratsios at the Endless Frontiers Retreat

THE GOLDEN AGE OF AMERICAN INNOVATION AS PREPARED FOR DELIVERY Endless Frontiers Retreat, Austin, Texas April 14, 2025 THE DIRECTOR: Thank you for the

whitehouse.gov

In Feb, I criticised Europe for wasting money and attention on over-inflated US tech hype cycles like genAI, the metaverse and blockchain: sciencebusiness.net/viewpoint/ai... Well, Germany's incoming government has gone one further. They're promising a test hyperloop route in their governing plan!

Viewpoint: Europe must stop chasing US technology hype cycles

Three weeks ago, the low-cost Chinese AI tool DeepSeek sent investors into a panic. On a shoestring budget, by AI standards, it managed to create a model that was comparable with the very best US tech...

sciencebusiness.net

1 in 3 Europeans think a cure for cancer exists, but is being hidden from the public for commercial reasons. A similar number say that “viruses have been produced in government labs to control our freedom.” 23% think early humans lived alongside dinosaurs. sciencebusiness.net/news/r-d-fun...

Data corner: Europeans’ views of science and technology

Europeans have widely divergent views on whether the private sector should be free to exploit new science and technology, or if the government should take firm control, according to a major survey of ...

sciencebusiness.net

My interview with the new Commissioner. What seemed to animate/exasperate her most was the level of inflexibility and red tape for Horizon Europe grants. "We talk about academic freedom, but if our applications and grant contracts are too complicated, there will be no freedom for researchers."

Nature@nature.com · last yr.

The European Union’s new research chief Ekaterina Zaharieva speaks to us about attracting disaffected US scientists and cutting grant bureaucracy https://go.nature.com/3FQQRaM

Despite China's continued rise as a science power, it actually seems to be attracting fewer, not more, foreign academics. There seems to have been an exodus during the pandemic - many just couldn't take the often draconian lockdowns. www.nature.com/articles/d41...

Foreign researchers in China face tightening restrictions

Data and security laws are affecting scientists who stayed in China after COVID — but for some it’s still a great place to do research.

nature.com